These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26203243)

  • 1. Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.
    Liu Q; Jung J; Somiya M; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Shin SH; Jeong SY; Choi EK; Kuroda S
    Int J Nanomedicine; 2015; 10():4159-72. PubMed ID: 26203243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.
    Li H; Tatematsu K; Somiya M; Iijima M; Kuroda S
    Acta Biomater; 2018 Jun; 73():412-423. PubMed ID: 29673839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
    Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
    J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.
    Matsuo H; Yoshimoto N; Iijima M; Niimi T; Jung J; Jeong SY; Choi EK; Sewaki T; Arakawa T; Kuroda S
    Int J Nanomedicine; 2012; 7():3341-50. PubMed ID: 22848163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.
    Yamada T; Jung J; Seno M; Kondo A; Ueda M; Tanizawa K; Kuroda S
    Cold Spring Harb Protoc; 2012 Jun; 2012(6):702-5. PubMed ID: 22661433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.
    Kasuya T; Jung J; Kinoshita R; Goh Y; Matsuzaki T; Iijima M; Yoshimoto N; Tanizawa K; Kuroda S
    Methods Enzymol; 2009; 464():147-66. PubMed ID: 19903554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
    Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
    Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
    Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
    Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
    Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins.
    Cho JE; Kim HS; Ahn WS; Park YS
    J Microencapsul; 2001; 18(4):421-31. PubMed ID: 11428672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
    Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
    Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect.
    Wang L; Wang Y; Ye Z; Yu Y; Wang C; Qiu L; Du X; Zhou S; Wang J; Jiang P
    Mol Pharm; 2024 May; 21(5):2394-2405. PubMed ID: 38647653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
    Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
    Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid.
    Wang S; Xu H; Xu J; Zhang Y; Liu Y; Deng YH; Chen D
    AAPS PharmSciTech; 2010 Jun; 11(2):870-7. PubMed ID: 20490957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.